<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The present study investigated the expression of the novel gene hBiot2 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) and its relationships with clinicopathological variables in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="1" pm="."><plain>The expression of hBiot2 in 163 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> together with the corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, 36 liver <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> and 5 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines was examined using real-time PCR </plain></SENT>
<SENT sid="2" pm="."><plain>In situ hybridization (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ISH</z:e>) was performed to evaluate the localization of hBiot2 expression in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="3" pm="."><plain>hBiot2 expression at the <z:chebi fb="40" ids="33697">RNA</z:chebi> level was localized in the nucleus of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells and <z:mpath ids='MPATH_458'>normal</z:mpath> epithelial cells </plain></SENT>
<SENT sid="4" pm="."><plain>The mean expression of hBiot2 in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (243.571±564.569) was higher compared to the <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (107.252±413.635, P&lt;0.0001) and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> samples (42.002±40.809, P=0.0002) </plain></SENT>
<SENT sid="5" pm="."><plain>hBiot2 expression was increased from stages I+II to III (P=0.047), and no difference in the expression was found in stages III and IV (P=0.452) </plain></SENT>
<SENT sid="6" pm="."><plain>A high value of hBiot2 was associated with a poorer prognosis compared with a low value independently of gender, age, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> site, stage and differentiation (P=0.007, RR 7.519, 95% CI 1.729-32.704) </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">Liver metastasis</z:e>, smaller <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, non-local recurrence and primary liver surgery alone were associated with a higher value of hBiot2 compared to larger <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, local recurrence and repeated liver surgery (P=0.003, 0.044 and 0.026, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>An inverse relationship was found between hBiot2 expression and the metastatic potential of the <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, increased expression of hBiot2 may be an early and interim event in the development of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>A higher expression of hBiot2 in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients independently indicates a poorer prognosis </plain></SENT>
</text></document>